Medical Facilities Corporation (DR) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of Medical Facilities Corporation stock C$25.04, price C$15.34, upside +63.2%, quality 70 out of 100. Rating: strongly undervalued. Calculated from audited financials with 23 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 8, 2026.
How to read this chart
60‑month range C$6.71 – C$18.42 · fair‑value band C$18.22 – C$34.07 · the C$15.34 price screens below the C$25.04 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 8, 2026.
Follow Medical Facilities in your weekly email
Every Wednesday you see whether Medical Facilities is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Medical Facilities Corporation, through its subsidiaries, owns and operates specialty surgical hospitals in the United States.
Show moreShow less
Its specialty surgical hospitals offer non-emergency surgical, imaging, diagnostic and pain management procedures, and other ancillary services, such as primary and urgent care.
The company is also involved in the facility fee charged to the patient, or insurer for the use of its infrastructure, surgical equipment, nursing staff, non-surgical professional services, drugs and supplies, and other support services.
Medical Facilities Corporation was incorporated in 2004 and is headquartered in Toronto, Canada.
Stock analysis
Medical Facilities Corporation (DR) currently trades at C$15.34, while our model-based Fair Value estimate is C$25.04, implying the stock looks roughly 39% undervalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of C$32.87 per share, and 19 of the 23 models we run sit above the C$15.34 price.
Bear case: the Economic Profit group reads lowest at C$14.04, and 4 of the 23 models stay below the price. Data coverage for this calculation is medium.
Scenario range: C$18.22 (bear) to C$34.07 (bull), the price of C$15.34 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 70/100 (solid quality), in the Healthcare sector.
Mixed Growth: Spin-off in 2024: revenue and profit before it include the divested business. Growth is measured afresh from 2024.
Medical Facilities Corporation reported revenue of $259M in FY2025 versus $399M in FY2021, a compound −10.3%/yr. Reported net income was $21.1M in FY2025, compounding +8.0%/yr from FY2021.
Key figures
Market cap C$262M (≈ $185M) Micro · P/E ratio 15.7 · P/S ratio 1.28 · EPS (TTM) C$0.9800 · Dividend yield 2.3% · Net margin 8.2% · Return on equity 36.8% · Return on assets (EBIT) 16.1% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 67 out of 100 (low confidence).
What moves the price
The share trades about 17% below its 52-week high and 10% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −1% fair-value upside, at 63%, DR screens cheaper than that median.
Fair Value models
BearC$18.22Fair Value C$25.04BullC$34.07
Price C$15.34 · Upside +63.2%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (C$0.5317 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.55/100
Spin-off in 2024: revenue and profit before it include the divested business. Growth is measured afresh from 2024.
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Basis: EBIT basis.
+4.6%
Earnings growth per share plus dividend.
Earnings per share, growth per year+2.3%
Dividend (yield on the price)2.3%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.base effect: 30.7% / 6.3%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.19% → 18%
Pace: the 5-year rate starts in 2020 (pandemic)
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−16.6%
The company could shrink this much every year for the next five years and today's price would still be justified.
What forecasts expect
n/a
No analyst forecast available.
After inflation (figures in USD, USA: IMF forecast 2.4% a year to 2030, 3.1% from 2016 to 2025) that is about −18.5% a year for the price.
Compare Medical Facilities Corporation with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Care Facilities · 234 stocks
Beats the industry median on 13/14 measures
Overall it ranks above its industry peers.
Valuation
Quality Score70 · Top 25%
Fair Value upside+63.2% · Top 25%
Profitability
Return on equity (12 months)36.8% · Top 25%
Return on assets7.8% · Above median
Net margin (12 months)14.6% · Top 25%
Operating margin (12 months)14.6% · Above median
Growth and dividend
Revenue growth (quarter YoY)7.8% · Above median
Dividend yield (12 months)2.3% · Above median
Balance sheet
Debt / equity0.36× · Above median
Valuation Multiplesvs Medical Care Facilities median · lower = cheaper
P/E (12 months)15.7× · Cheaper than median
P/B2.46× · book value is mostly goodwill ⓘGoodwill and other intangible assets are larger than the equity. The book value mainly reflects prices paid for past acquisitions, so we do not rank this P/B against the peer group.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Medical Facilities Corporation (DR) overvalued or undervalued?
As of Nov 8, 2026, our model estimates a fair value of C$25.04 versus a price of C$15.34, about +63% upside (undervalued).
What is the fair value of DR?
Our model-based fair value for Medical Facilities Corporation is C$25.04 (as of Nov 8, 2026), built from audited fundamentals. The current price: C$15.34.
What is the quality score of DR?
Medical Facilities Corporation has a Quality Score of 70/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Medical Facilities Corporation (DR)?
Our model-based price target is the fair value of C$25.04 (as of Nov 8, 2026) from 23 valuation models. Cautious scenario C$18.22, optimistic scenario C$34.07. It is a calculation from audited fundamentals, not an analyst target.
What is the Medical Facilities Corporation stock forecast for 2026?
Our models put fair value at C$25.04, about +63% upside versus a price of C$15.34 (undervalued). Cautious scenario C$18.22, optimistic scenario C$34.07. The calculation is refreshed regularly with new filings.
What is the revenue of Medical Facilities Corporation (DR)?
Medical Facilities Corporation reported trailing-twelve-month revenue of about $265M (latest available figure, as of Nov 8, 2026).
Does Medical Facilities Corporation pay a dividend?
Medical Facilities Corporation currently shows a dividend yield of 2.35% relative to its recent price (as of Nov 8, 2026).
How much is the dividend of Medical Facilities Corporation (DR) and when is the ex-dividend date?
Medical Facilities Corporation pays a dividend of C$0.36 per share a year, a dividend yield of 2.3%. The last ex-dividend date was Oct 1, 2026. A dividend has been paid every year since at least 2004. The payout ratio is 19.6% of earnings. Free cash flow covers the dividend 9.91 times. Our assessment: Well covered. A low payout and the dividend is fully funded by free cash flow, a comfortable, sustainable dividend.
What growth is priced into Medical Facilities Corporation (DR)?
For today's price to be fair in a discounted-cash-flow model, Medical Facilities Corporation would have to grow free cash flow by -16.6 % per year for five years (discount rate 11.0 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew -6.6 % per year. As of Nov 8, 2026.
What discount rate (WACC) does the fair value of DR use?
Our models discount Medical Facilities Corporation at 11.0 %: a base by market capitalisation (micro), damped by beta 0.35, country premium for Canada. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Medical Facilities Corporation that is -16.6 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (11.0 %) and the same formula as our fair value.
How much growth has Medical Facilities Corporation (DR) delivered so far?
Over the past 5 years revenue at Medical Facilities Corporation grew -6.6 % a year. The price currently implies free-cash-flow growth of -16.6 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Medical Facilities Corporation (DR) growing?
The median revenue growth in the sector is +6.2 % a year. That is the yardstick for the growth priced into Medical Facilities Corporation (-16.6 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Medical Facilities Corporation (DR)?
The free-cash-flow yield on the price is 22.11 %: that much free cash flow Medical Facilities Corporation produces per unit of market value. When it exceeds the discount rate of our models (11.0 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Medical Facilities Corporation (DR)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Medical Facilities Corporation it is C$25.04 per share (as of Nov 8, 2026), against a price of C$15.34. It is the blended result of 23 valuation models in 8 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is Medical Facilities Corporation stock overvalued or undervalued in 2026?
As of Nov 8, 2026, DR trades below its calculated fair value: price C$15.34, fair value C$25.04, a gap of about +63% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of DR?
No. The price is what the market pays today (C$15.34); the fair value is what the company's own numbers justify (C$25.04). For Medical Facilities Corporation the two are C$9.70 per share apart. That gap is exactly why we show both numbers side by side.
How much is Medical Facilities Corporation worth?
The market values Medical Facilities Corporation at about C$262M (market capitalisation, as of Nov 8, 2026). Per share that is C$15.34; our models calculate a fair value of C$25.04 per share.
What do the bullish and bearish scenarios say about DR?
Our models span a range for Medical Facilities Corporation: cautious scenario C$18.22, base C$25.04, optimistic C$34.07 per share (as of Nov 8, 2026, price C$15.34). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of DR?
Medical Facilities Corporation trades at a price-to-earnings ratio of 15.7 (as of Nov 8, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of C$25.04 is built from several models across several years. Median P/E at fiscal year-end, 9 fiscal years (2016 to 2025), reported earnings: 14.9. Other multiples: PEG 0.9, P/B 2.5, P/S 0.7, EV/EBITDA 3.1.
What is the PEG ratio of DR?
The PEG ratio of Medical Facilities Corporation is 0.86 (P/E divided by earnings growth, as of Nov 8, 2026). That is below 1, so growth is priced more cheaply than the earnings multiple alone suggests.
How solid is the balance sheet of Medical Facilities Corporation (DR)?
Balance-sheet figures for Medical Facilities Corporation (as of Nov 8, 2026): return on equity 36.8%, debt of 0.36 per unit of equity. They feed the Quality Score of 70/100, which measures business quality independently of the share price.
How far is DR from its 52-week high?
Medical Facilities Corporation trades at C$15.34, about 17% below its 52-week high of C$18.42 and 10% above the low of C$14.00 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of C$25.04 is for.
Which stocks are comparable to Medical Facilities Corporation?
From the same area (Healthcare) we also value HCA Healthcare, Inc, Fresenius SE, Tenet Healthcare Corporation, Dr. Sulaiman Al Habib Medical Services Group, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Medical Facilities Corporation stock attractive at the current price?
The data as of Nov 8, 2026: price C$15.34, calculated fair value C$25.04 (+63%), Quality Score 70/100, from 23 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of DR calculated?
We run Medical Facilities Corporation through 23 models from 8 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of C$25.04 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Medical Facilities Corporation currently trades 39% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Medical Facilities Corporation (DR)?
The closing price on Nov 6, 2026 was C$15.34. Our model-based fair value is C$25.04, about +63% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Medical Facilities Corporation right now?
The price is below even our cautious bear case (C$18.22). The market is more pessimistic than our downside scenario. Solid quality (70/100) at a price below fair value, the discount is the argument here, not the business quality. A fairly wide model range (C$18.22 to C$34.07) leaves room in how you read the outcome.
Where does the earnings growth of Medical Facilities Corporation (DR) come from?
Earnings per share at Medical Facilities Corporation grew +9.7 % a year from 2014 to 2025. Broken into its drivers: revenue per share +6.6 %, EBIT margin −2.9 %, tax rate +3.6 %, residual (interest, one-offs) +2.2 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Medical Facilities Corporation
How large is the market capitalisation of Medical Facilities Corporation (DR)?
The market capitalisation of Medical Facilities Corporation is C$262M (≈ $185M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Medical Facilities Corporation (DR)?
The price-to-sales ratio of Medical Facilities Corporation is 1.28 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Medical Facilities Corporation (DR)?
Earnings per share at Medical Facilities Corporation are C$0.9800 (price ÷ EPS = P/E 15.7). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Medical Facilities Corporation (DR)?
The dividend yield of Medical Facilities Corporation is 2.3% (payout 36.7%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Medical Facilities Corporation (DR)?
The net margin of Medical Facilities Corporation is 8.2% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Medical Facilities Corporation (DR)?
The return on equity (ROE) of Medical Facilities Corporation is 36.8% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Medical Facilities Corporation (DR)?
On an EBIT basis the return on assets of Medical Facilities Corporation is 16.1% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Medical Facilities Corporation (DR)?
The operating margin of Medical Facilities Corporation is 14.6% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Medical Facilities Corporation (DR)?
Revenue at Medical Facilities Corporation is growing +7.8% versus a year earlier (3y avg −15.2%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Medical Facilities Corporation (DR)?
Earnings per share at Medical Facilities Corporation are growing −55.0% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Medical Facilities Corporation (DR) carry?
The net debt of Medical Facilities Corporation is $15.4M (fiscal year 2025, ≈ 0.4 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Medical Facilities Corporation in the live analysis
One click puts Medical Facilities Corporation on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Some data
Nov 8, 2026